Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy

Audrey M Sigmund,* Kieran D Sahasrabudhe,* Bhavana Bhatnagar Division of Hematology, Department of Internal Medicine, The Ohio State University and the Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA*These authors contributed equally to this workCorrespondence: Bhavana Bha...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sigmund AM, Sahasrabudhe KD, Bhatnagar B
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
mrd
Acceso en línea:https://doaj.org/article/b11495eba1d74f478741d26b3469e17b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares